Cited by 322Food Allergy and Anaphylaxis ResearchPharmacovigilance and Adverse Drug ReactionsDrug-Induced Adverse Reactions

The DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.

Risk of anaphylaxis after vaccination of children and adolescents.

Bohlke, Kari, Davis, Robert L., Marcy, S. M., Braun, M. M., DeStefano, Frank, Black, Steven B., Mullooly, John P., Thompson, Robert S., for the Vaccine Safety Datalink Team·2003·PEDIATRICS

DOI 10.1542/peds.112.4.815

Open this paper in CoChat — free account

Abstract

OBJECTIVE: To quantify the risk of anaphylaxis after vaccination of children and adolescents. METHODS: The study population consisted of children and adolescents who were enrolled at 4 health maintenance organizations that participated in the Vaccine Safety Datalink Project. For the period 1991-1997, we identified potential cases by searching for occurrences of International Classification of Diseases, Ninth Revision (ICD-9) code 995.0 (anaphylactic shock), E948.0 through E948.9 (adverse reaction from bacterial vaccines), and E949.0 through E949.9 (adverse reaction from other vaccines and biological substances). At 1 study site, we also included a range of other allergy codes. We restricted to diagnoses on days 0 to 2 after vaccination (ICD-9 995.0) or day 0 (all other ICD-9 codes). We then reviewed the medical record to confirm the diagnosis. RESULTS: We identified 5 cases of potentially vaccine-associated anaphylaxis after administration of 7 644 049 vaccine doses, for a risk of 0.65 cases/million doses (95% confidence interval: 0.21-1.53). None of the episodes resulted in death. Vaccines that were administered before the anaphylactic episodes were generally given in combination and included measles-mumps-rubella, hepatitis B, diphtheria-tetanus, diphtheria-tetanus-pertussis, Haemophilus influenzae type b, and oral polio vaccine. One case of anaphylaxis followed measles-mumps-rubella vaccine alone. At the site at which we reviewed additional allergy codes, we identified 1 case after 653 990 vaccine doses, for a risk of 1.53 cases/million doses (95% confidence interval: 0.04-8.52). CONCLUSIONS: Patients and health care providers can be reassured that vaccine-associated anaphylaxis is a rare event. Nevertheless, providers should be prepared to provide immediate medical treatment should it occur.

Integrity signals

Registry

Crossref · 10.1542/peds.112.4.815

Cites

25 of 25 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Epidemiology and Prevention of Vaccine-Preventable Diseases
Atkinson, W. W. (2009) · Cited by 1,862
Allergy: Principles and Practice.
(1991) · Annals of Internal Medicine · doi:10.7326/0003-4819-114-9-817_10 · Cited by 1,698
Recommendations of the Advisory Committee on Immunization Practices (ACIP)
Harpaz, R., Ortega‐Sanchez, I. R., & Seward, J. F. (2008) · Cited by 1,302
The Vaccine Adverse Event Reporting System (VAERS)
CHEN, R., RASTOGI, S., MULLEN, J., HAYES, S., COCHI, S., DONLON, J., & WASSILAK, S. (1994) · Vaccine · doi:10.1016/0264-410x(94)90315-8 · Cited by 498
The Vaccine Adverse Event Reporting System (VAERS)
(1994) · Vaccine · doi:10.1016/0264-410x(94)90044-2 · Cited by 392
Postlicensure Safety Surveillance for Varicella Vaccine
Wise, R. P. (2000) · JAMA · doi:10.1001/jama.284.10.1271 · Cited by 214
Adverse Events Associated with Childhood Vaccines
Institute of Medicine (1994) · National Academies Press eBooks · doi:10.17226/2138 · Cited by 214
Serious adverse events after measles-mumps-rubella vaccination during a fourteen-year prospective follow-up
Patja, A., Davidkin, I., Kurki, T., KALLIO, M. J. T., Valle, M., & Peltola, H. (2000) · The Pediatric Infectious Disease Journal · doi:10.1097/00006454-200012000-00002 · Cited by 193
A 7-YEAR SURVEY OF DISORDERS ATTRIBUTED TO VACCINATION IN NORTH WEST THAMES REGION
Pollock, T. M. (1983) · The Lancet · doi:10.1016/s0140-6736(83)92037-8 · Cited by 156
Underreporting of anaphylaxis in a community emergency room
Klein, J. S., & Yocum, M. W. (1995) · Journal of Allergy and Clinical Immunology · doi:10.1016/s0091-6749(95)70329-2 · Cited by 153

Show all 24 references

Sorted by citations

Prevention and Control of Influenza: Recommendations of the Advisory Committee on Immunization Practices (ACIP)
Fiore, A. E., Shay, D. K., Broder, K. R., Iskander, J. K., Uyeki, T. M., Mootrey, G., Bresee, J. S., & Cox, N. S. (2001) · PsycEXTRA Dataset · doi:10.1037/e548312006-001 · Cited by 5,006
Sexually Transmitted Infections Treatment Guidelines, 2021
Workowski, K. A., Bachmann, L. H., Chan, P. A., Johnston, C. M., Muzny, C. A., Park, I., Reno, H., Zenilman, J. M., & Bolan, G. A. (2021) · MMWR. Recommendations and Reports · doi:10.15585/mmwr.rr7004a1 · Cited by 3,018
Prevention and control of influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2010.
Fiore, A. E., Uyeki, T. M., Broder, K. R., Finelli, L., Euler, G. L., Singleton, J. A., Iskander, J. K., Wortley, P. M., Shay, D. K., Bresee, J., et al. (2009) · PubMed · Cited by 1,964
Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices—United States, 2018–19 Influenza Season
Grohskopf, L. A., Sokolow, L. Z., Broder, K. R., Walter, E. B., Fry, A. M., & Jernigan, D. B. (2018) · MMWR Recommendations and Reports · doi:10.15585/mmwr.rr6703a1 · Cited by 1,640
A guide to vaccinology: from basic principles to new developments
Pollard, A. J., & Bijker, E. M. (2021) · Nature Reviews Immunology · doi:10.1038/s41577-020-00479-7 · Cited by 1,593
A comprehensive immunization strategy to eliminate transmission of hepatitis B virus infection in the United States: recommendations of the Advisory Committee on Immunization Practices (ACIP) Part II: immunization of adults.
Mast, E. E., Weinbaum, C. M., Fiore, A. E., Alter, M. J., Bell, B. P., Finelli, L., Rodewald, L. E., Douglas, J. M., Janssen, R. S., & Ward, J. W. (2006) · PubMed · Cited by 1,129
Prevention of hepatitis B virus infection in the United States: recommendations of the Advisory Committee on Immunization Practices.
Schillie, S., Vellozzi, C., Reingold, A., Harris, A., Haber, P., Ward, J. W., & Nelson, N. P. (2018) · MMWR. Recommendations and Reports · doi:10.15585/mmwr.rr6701a1 · Cited by 815
A Comprehensive Immunization Strategy to Eliminate Transmission of Hepatitis B Virus Infection in the United States: Recommendations of the Advisory Committee on Immunization Practices (ACIP): Part 1: Immunization of Infants, Children, and Adolescents
Mast, E. E., Margolis, H. S., Fiore, A. E., Brink, E. W., Goldstein, S. T., Wang, S. A., Moyer, L. A., Bell, B. P., & Alter, M. J. (2005) · PsycEXTRA Dataset · doi:10.1037/e548682006-001 · Cited by 751
Immunisation against infectious disease
SALISBURY, D. M., Ramsay, M. E., & Noakes, K. (2006) · Stationery Office eBooks · Cited by 636
Prevention and Control of Seasonal Influenza with Vaccines
Grohskopf, L. A., Sokolow, L. Z., Broder, K. R., Olsen, S. J., Karron, R. A., Jernigan, D. B., & Bresee, J. (2016) · MMWR Recommendations and Reports · doi:10.15585/mmwr.rr6505a1 · Cited by 602
Epidemiology of anaphylaxis: findings of the American College of Allergy, Asthma and Immunology Epidemiology of Anaphylaxis Working Group
Lieberman, P., Camargo, C. A., Bohlke, K., Jick, H., Miller, R. L., Sheikh, A., & Simons, F. E. R. (2006) · Annals of Allergy Asthma & Immunology · doi:10.1016/s1081-1206(10)61086-1 · Cited by 480
Self-citation
Hepatitis B vaccines
Shouval, D. (2003) · Journal of Hepatology · doi:10.1016/s0168-8278(03)00152-1 · Cited by 474
Prevention and control of seasonal influenza with vaccines. Recommendations of the Advisory Committee on Immunization Practices--United States, 2013-2014.
Grohskopf, L. A., Shay, D. K., Shimabukuro, T. T., Sokolow, L. Z., Keitel, W. A., Bresee, J., & Cox, N. J. (2013) · PubMed · Cited by 471
Effect of hepatitis B immunisation in newborn infants of mothers positive for hepatitis B surface antigen: systematic review and meta-analysis
Lee, C., Gong, Y., Brok, J. S., Boxall, E. H., & Gluud, C. N. (2006) · BMJ · doi:10.1136/bmj.38719.435833.7c · Cited by 400
Epidemiology of life-threatening and lethal anaphylaxis: a review
Moneret‐Vautrin, D. A., Morisset, M., Flabbee, J., Beaudouin, E., & Kanny, G. (2005) · Allergy · doi:10.1111/j.1398-9995.2005.00785.x · Cited by 386
Anaphylaxis: Case definition and guidelines for data collection, analysis, and presentation of immunization safety data
Rüggeberg, J. U., Gold, M., Bayas, J. M., Blum, M. D., Bonhoeffer, J., Friedlander, S. F., Brito, G. D. S., Heininger, U., Imoukhuede, E. B., Khamesipour, A., et al. (2007) · Vaccine · doi:10.1016/j.vaccine.2007.02.064 · Cited by 383
Risk of anaphylaxis after vaccination in children and adults.
McNeil, M. M., Weintraub, E. S., Duffy, J., Sukumaran, L., Jacobsen, S. J., Klein, N. P., Hambidge, S. J., Lee, G. M., Jackson, L. A., Irving, S. A., et al. (2016) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2015.07.048 · Cited by 381
Self-citation
Preventing tetanus, diphtheria, and pertussis among adults: use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine recommendations of the Advisory Committee on Immunization Practices (ACIP) and recommendation of ACIP, supported by the Healthcare Infection Control Practices Advisory Committee (HICPAC), for use of Tdap among health-care personnel.
Kretsinger, K., Broder, K. R., Cortese, M. M., Joyce, M. P., Ortega‐Sanchez, I. R., Lee, G. M., Tiwari, T., Cohn, A. C., Slade, B. A., Iskander, J. K., et al. (2006) · PubMed · Cited by 373
The Vaccine Safety Datalink: A Model for Monitoring Immunization Safety
Baggs, J. M., Gee, J. M., Lewis, E. M., Fowler, G. L., Benson, P. J., Lieu, T. A., Naleway, A. L., Klein, N. P., Baxter, R. P., Belongia, E. A., et al. (2011) · PEDIATRICS · doi:10.1542/peds.2010-1722h · Cited by 349
Adverse Effects of Vaccines: Evidence and Causality
Stratton, K. R., Ford, A. Q., Rusch, E., & Clayton, E. W. (2013) · Cited by 346
Adverse reactions to vaccines practice parameter 2012 update
Kelso, J. M., Greenhawt, M., Li, J. T., Nicklas, R. A., Bernstein, D. I., Blessing-Moore, J., Cox, L., Khan, D. A., Lang, D. M., Oppenheimer, J. J., et al. (2012) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2012.04.003 · Cited by 293
Epidemiology of anaphylaxis among children and adolescents enrolled in a health maintenance organization.
Bohlke, K., Davis, R. L., Destefano, F., Marcy, S. M., Braun, M. M., & Thompson, R. S. (2004) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2003.11.033 · Cited by 285
Self-citation
Vaccine-associated hypersensitivity
McNeil, M. M., & Destefano, F. R. (2018) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2017.12.971 · Cited by 274
Self-citation
Hepatitis B vaccination: The key towards elimination and eradication of hepatitis B
Chen, D. (2009) · Journal of Hepatology · doi:10.1016/j.jhep.2009.01.002 · Cited by 259
Economic Evaluation of the Routine Childhood Immunization Program in the United States, 2009
Zhou, F., Shefer, A. M., Wenger, J. D., Messonnier, M. L., Wang, L. Y., Lopez, A. S., Moore, M. R., Murphy, T. V., Cortese, M. M., & Rodewald, L. E. (2014) · PEDIATRICS · doi:10.1542/peds.2013-0698 · Cited by 257
Importance of background rates of disease in assessment of vaccine safety during mass immunisation with pandemic H1N1 influenza vaccines
BLACK, S. B., Eskola, J., Siegrist, C., Halsey, N. A., MacDonald, N. E., LAW, B. J., Miller, E., Andrews, N. J., Stowe, J., Salmon, D. A., et al. (2009) · The Lancet · doi:10.1016/s0140-6736(09)61877-8 · Cited by 254
Self-citation
The Vaccine Safety Datalink: successes and challenges monitoring vaccine safety
McNeil, M. M., Gee, J. M., Weintraub, E., Belongia, E. A., Lee, G. M., Glanz, J. M., Nordin, J. D., Klein, N. P., Baxter, R. P., Naleway, A. L., et al. (2014) · Vaccine · doi:10.1016/j.vaccine.2014.07.073 · Cited by 247
Self-citation
Monitoring the safety of quadrivalent human papillomavirus vaccine: Findings from the Vaccine Safety Datalink
Gee, J. M., Naleway, A. L., Shui, I. M., Baggs, J. M., Yin, R., Li, R., Kulldorff, M., Lewis, E. M., FIREMAN, B. H., Daley, M. F., et al. (2011) · Vaccine · doi:10.1016/j.vaccine.2011.08.106 · Cited by 237
International Consensus (ICON): allergic reactions to vaccines
Dreskin, S. C., Halsey, N. A., Kelso, J. M., Wood, R. A., Hummell, D. S., Edwards, K. M., Caubet, J., Engler, R. J. M., Gold, M., Ponvert, C., et al. (2016) · World Allergy Organization Journal · doi:10.1186/s40413-016-0120-5 · Cited by 195
Safety of trivalent inactivated influenza vaccines in adults: Background for pandemic influenza vaccine safety monitoring
Vellozzi, C., Burwen, D. R., Dobardzic, A., Ball, R., Walton, K., & Haber, P. (2009) · Vaccine · doi:10.1016/j.vaccine.2009.01.125 · Cited by 188
Hepatitis B immunisation for newborn infants of hepatitis B surface antigen-positive mothers
Lee, C., Gong, Y., Brok, J. S., Boxall, E. H., & Gluud, C. N. (2006) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004790.pub2 · Cited by 189
Immune‐mediated adverse reactions to vaccines
Stone, C. A., Rukasin, C. R. F., Beachkofsky, T. M., & Phillips, E. J. (2019) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.14112 · Cited by 180
Generalized urticaria induced by the Na-ASP-2 hookworm vaccine: Implications for the development of vaccines against helminths
Diemert, D. J., Pinto, A. G. S., Freire, J. D. M., Jariwala, A. R., Santiago, H. C., Hamilton, R. G., Periago, M. V., Loukas, A. C., Tribolet, L., Mulvenna, J. P., et al. (2012) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2012.04.027 · Cited by 176
Vaccination and allergy: EAACI position paper, practical aspects
Nilsson, L. J., Brockow, K., Alm, J. S., Cardona, V., Caubet, J., Gomes, E. R., Jenmalm, M. C., Lau, S., Netterlid, E., Schwarze, J., et al. (2017) · Pediatric Allergy and Immunology · doi:10.1111/pai.12762 · Cited by 151
Hepatitis B Vaccination, Screening, and Linkage to Care: Best Practice Advice From the American College of Physicians and the Centers for Disease Control and Prevention
Abara, W. E., Qaseem, A., Schillie, S. F., McMahon, B. J., & Harris, A. M. (2017) · Annals of Internal Medicine · doi:10.7326/m17-1106 · Cited by 150
Adverse Events Reported Following Live, Cold-Adapted, Intranasal Influenza Vaccine
Izurieta, H. S. (2005) · JAMA · doi:10.1001/jama.294.21.2720 · Cited by 139
Near Real-Time Surveillance for Influenza Vaccine Safety: Proof-of-Concept in the Vaccine Safety Datalink Project
Greene, S. K., Kulldorff, M., Lewis, E. M., Li, R., Yin, R., Weintraub, E., FIREMAN, B. H., Lieu, T. A., Nordin, J. D., Glanz, J. M., et al. (2009) · American Journal of Epidemiology · doi:10.1093/aje/kwp345 · Cited by 132
Measles vaccine
Strebel, P. M., Papania, M. J., Dayan, G. H., & Halsey, N. A. (2008) · Elsevier eBooks · doi:10.1016/b978-1-4160-3611-1.50022-2 · Cited by 132
H1N1 and Seasonal Influenza Vaccine Safety in the Vaccine Safety Datalink Project
Lee, G. M., Greene, S. K., Weintraub, E., Baggs, J. M., Kulldorff, M., FIREMAN, B. H., Baxter, R. P., Jacobsen, S. J., Irving, S. A., Daley, M. F., et al. (2011) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2011.04.004 · Cited by 130
Self-citation
Nosocomial Pertussis: Costs of an Outbreak and Benefits of Vaccinating Health Care Workers
Calugar, A., Ortega‐Sanchez, I. R., Tiwari, T., Oakes, L., Jahre, J. A., & Murphy, T. V. (2006) · Clinical Infectious Diseases · doi:10.1086/500321 · Cited by 130
Pertussis in Adolescents and Adults: Should We Vaccinate?
Lee, G. M., LeBaron, C. W., Murphy, T. V., Lett, S. M., Schauer, S. L., & Lieu, T. A. (2005) · PEDIATRICS · doi:10.1542/peds.2004-2509 · Cited by 127
The Epidemiology of Anaphylaxis
Yu, J. E., & Lin, R. Y.-W. (2015) · Clinical Reviews in Allergy & Immunology · doi:10.1007/s12016-015-8503-x · Cited by 126
Anaphylaxis following quadrivalent human papillomavirus vaccination
Brotherton, J. M. L., Gold, M., Kemp, A. S., McIntyre, P. B., Burgess, M. A., Campbell‐Lloyd, S., & Panel, O. B. O. T. N. S. W. H. H. A. E. (2008) · Canadian Medical Association Journal · doi:10.1503/cmaj.080916 · Cited by 126
Adverse events following influenza A (H1N1) 2009 monovalent vaccines reported to the Vaccine Adverse Event Reporting System, United States, October 1, 2009–January 31, 2010
Vellozzi, C. J., Broder, K. R., Haber, P., Guh, A. Y., Nguyen, M., Cano, M. V., Lewis, P., McNeil, M. M., Bryant, M., Singleton, J. A., et al. (2010) · Vaccine · doi:10.1016/j.vaccine.2010.09.021 · Cited by 125
Self-citation
An Algorithm for Treatment of Patients With Hypersensitivity Reactions After Vaccines
Wood, R. A., Berger, M., Dreskin, S. C., Setse, R. W., Engler, R. J. M., Dekker, C. L., & Halsey, N. A. (2008) · PEDIATRICS · doi:10.1542/peds.2008-1002 · Cited by 124
Recommended vaccinations for asplenic and hyposplenic adult patients
Bonanni, P., Grazzini, M., Niccolai, G., Paolini, D., Varone, O., Bartoloni, A., Bartalesi, F., Santini, M. G., Baretti, S., Bonito, C., et al. (2016) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2017.1264797 · Cited by 124
Anaphylaxis after vaccination reported to the Vaccine Adverse Event Reporting System, 1990-2016
Su, J. R., Moro, P. L., Ng, C. S., Lewis, P. W., Said, M. A., & Cano, M. V. (2019) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2018.12.1003 · Cited by 116
Vaccines and allergic reactions: The past, the current COVID‐19 pandemic, and future perspectives
Sampath, V., Rabinowitz, G., Shah, M. M., Jain, S., Diamant, Z., Jeseňák, M., Rabin, R. L., Vieths, S., Agache, I. O., Akdiş, M., et al. (2021) · Allergy · doi:10.1111/all.14840 · Cited by 117
Vaccine allergies
Chung, E. H. (2014) · Clinical and Experimental Vaccine Research · doi:10.7774/cevr.2014.3.1.50 · Cited by 114
Epidemiology of anaphylaxis
Lieberman, P. (2008) · Current Opinion in Allergy and Clinical Immunology · doi:10.1097/aci.0b013e3283036a69 · Cited by 109
Human antibody response to N-glycans present on plant-made influenza virus-like particle (VLP) vaccines.
Ward, B., Landry, N., Trépanier, S., Mercier, G., Dargis, M., Couture, M., D'Aoust, M.-A., & Vézina, L. (2014) · Vaccine · doi:10.1016/j.vaccine.2014.08.079 · Cited by 98
Vaccination of yeast sensitive individuals: review of safety data in the US vaccine adverse event reporting system (VAERS)
DiMiceli, L. E., Pool, V., Kelso, J. M., Shadomy, S. V., Iskander, J., & V.A.E.R.S. Team (2005) · Vaccine · doi:10.1016/j.vaccine.2005.07.069 · Cited by 93
Deaths following vaccination: What does the evidence show?
Miller, E. R., Moro, P. L., Cano, M. V., & Shimabukuro, T. T. (2015) · Vaccine · doi:10.1016/j.vaccine.2015.05.023 · Cited by 88
Diagnosis and management of drug‐induced anaphylaxis in children: An EAACI position paper
Atanasković‐Marković, M., Gomes, E. R., Cernadas, J., Toit, G. D., Kidon, M. I., Kuyucu, S., Mori, F., Ponvert, C., Terreehorst, I., & Caubet, J. (2019) · Pediatric Allergy and Immunology · doi:10.1111/pai.13034 · Cited by 87
Mechanisms Underlying Adverse Reactions to Vaccines
Siegrist, C. (2007) · Journal of Comparative Pathology · doi:10.1016/j.jcpa.2007.04.012 · Cited by 87
Epidemiology of Anaphylaxis
Clark, S., & Camargo, C. A. (2007) · Immunology and Allergy Clinics of North America · doi:10.1016/j.iac.2007.03.002 · Cited by 82
Cost Effectiveness of Pertussis Vaccination in Adults
Lee, G. M., Murphy, T. V., Lett, S. M., Cortese, M. M., Kretsinger, K., Schauer, S. L., & Lieu, T. A. (2007) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2006.10.016 · Cited by 78
Vaccine hypersensitivity - update and overview
Fritsche, P. (2010) · Swiss Medical Weekly · doi:10.4414/smw.2010.12980 · Cited by 77
Recommendations for the administration of influenza vaccine in children allergic to egg
Erlewyn‐Lajeunesse, M., Brathwaite, N., Lucas, J. S., & Warner, J. O. (2009) · BMJ · doi:10.1136/bmj.b3680 · Cited by 67
Questions regarding the safety and duration of immunity following live yellow fever vaccination
Amanna, I. J., & Slifka, M. K. (2016) · Expert Review of Vaccines · doi:10.1080/14760584.2016.1198259 · Cited by 69
Immediate hypersensitivity reactions following monovalent 2009 pandemic influenza A (H1N1) vaccines: Reports to VAERS
Halsey, N. A., Griffioen, M. A., Dreskin, S. C., Dekker, C. L., Wood, R. J. K., Sharma, D., Jones, J. F., LaRussa, P. S., Garner, J., Berger, M., et al. (2013) · Vaccine · doi:10.1016/j.vaccine.2013.09.066 · Cited by 61
Anaphylaxis: Revision of the Brighton collaboration case definition
Gold, M., Amarasinghe, A., Greenhawt, M., Kelso, J. M., Kochhar, S., Thong, B. Y., Top, K. A., Turner, P., Worm, M., & LAW, B. J. (2022) · Vaccine · doi:10.1016/j.vaccine.2022.11.027 · Cited by 61
Safety review of the purified chick embryo cell rabies vaccine: Data from the Vaccine Adverse Event Reporting System (VAERS), 1997–2005
Dobardzic, A., Izurieta, H. S., Woo, E. J., Iskander, J., Shadomy, S. V., Rupprecht, C. E., Ball, R., & Braun, M. M. (2007) · Vaccine · doi:10.1016/j.vaccine.2007.02.075 · Cited by 61
Self-citation
Adverse reactions to vaccines
Kelso, J. M., Li, J. T., Nicklas, R. A., Blessing-Moore, J., Cox, L., Lang, D. M., Oppenheimer, J., Portnoy, J. M., Randolph, C., Schuller, D. E., et al. (2009) · Annals of Allergy Asthma & Immunology · doi:10.1016/s1081-1206(10)60350-x · Cited by 59
Drug-Induced Anaphylaxis
Leone, R., Conforti, A., Venegoni, M., Motola, D., Moretti, U., Meneghelli, I., Cocci, A., Cellini, G. S., Scotto, S., Montanaro, N., et al. (2005) · Drug Safety · doi:10.2165/00002018-200528060-00006 · Cited by 59
Economic and Behavioral Influencers of Vaccination and Antimicrobial Use
Wagner, C. E., Prentice, J. A., Saad-Roy, C. M., Yang, L., Grenfell, B. T., Levin, S. A., & Laxminarayan, R. (2020) · Frontiers in Public Health · doi:10.3389/fpubh.2020.614113 · Cited by 56
Measles Vaccines
Strebel, P. M., Papania, M. J., Gastañaduy, P. A., & Goodson, J. L. (2017) · Elsevier eBooks · doi:10.1016/b978-0-323-35761-6.00037-7 · Cited by 55
Vaccine Allergy
Caubet, J., & Ponvert, C. (2014) · Immunology and Allergy Clinics of North America · doi:10.1016/j.iac.2014.04.004 · Cited by 58
Tick-borne encephalitis vaccines: past and present
Zent, O., & Bröker, M. (2005) · Expert Review of Vaccines · doi:10.1586/14760584.4.5.747 · Cited by 52
Vaccination of persons allergic to latex: a review of safety data in the Vaccine Adverse Event Reporting System (VAERS)
Russell, M. L., Pool, V., Kelso, J. M., & Tomazic‐Jezic, V. J. (2004) · Vaccine · doi:10.1016/j.vaccine.2004.06.042 · Cited by 52
Safety of Measles-Containing Vaccines in 1-Year-Old Children
Klein, N. P., Lewis, E. M., FIREMAN, B. H., Hambidge, S. J., Naleway, A. L., Nelson, J. C., Belongia, E. A., Yih, W. K., Nordin, J. D., Hechter, R. C., et al. (2015) · PEDIATRICS · doi:10.1542/peds.2014-1822 · Cited by 50
The clinician’s guide to the anti-vaccinationists’ galaxy
Poland, G. A., & Jacobson, R. M. (2012) · Human Immunology · doi:10.1016/j.humimm.2012.03.014 · Cited by 51
Post-licensure rapid immunization safety monitoring program (PRISM) data characterization
Baker, M. A., Nguyen, M., Cole, D. V., Lee, G. M., & Lieu, T. A. (2013) · Vaccine · doi:10.1016/j.vaccine.2013.04.088 · Cited by 50
Elimination of Vertical Transmission of Hepatitis B in Africa: A Review of Available Tools and New Opportunities
Dionne‐Odom, J., Njei, B. M., & Tita, A. (2018) · Clinical Therapeutics · doi:10.1016/j.clinthera.2018.05.016 · Cited by 49
A history of hookworm vaccine development
Schneider, B. C., Jariwala, A. R., Periago, M. V., Gazzinelli, M. F., Bose, S. N., Hotez, P. J., Diemert, D. J., & Bethony, J. M. (2011) · Human Vaccines · doi:10.4161/hv.7.11.18443 · Cited by 49
Simultaneous quantification of the viral antigens hemagglutinin and neuraminidase in influenza vaccines by LC–MSE
Creskey, M., Li, C., Wang, J., Girard, M., Lorbetskie, B., Gravel, C., Farnsworth, A., Li, X., Smith, D. G. S., & Cyr, T. D. (2012) · Vaccine · doi:10.1016/j.vaccine.2012.05.036 · Cited by 48
Leitlinie Neurodermitis [atopisches Ekzem; atopische Dermatitis]
Werfel, T., Aberer, W., Ahrens, F., Matthias, A., Biedermann, T., Diepgen, T., Regina, F., Gieler, U., Heratizadeh, A., Kahle, J., et al. (2015) · JDDG Journal der Deutschen Dermatologischen Gesellschaft · doi:10.1111/ddg.12884 · Cited by 45
Hypersensitivity reactions to the Sabin vaccine in children with cow's milk allergy
Parisi, C. A. S., Smaldini, P., Gervasoni, M. E., Maspero, J. F., & Docena, G. H. (2012) · Clinical & Experimental Allergy · doi:10.1111/cea.12059 · Cited by 45
Anaphylaxis as an adverse event following immunisation in the UK and Ireland
Erlewyn‐Lajeunesse, M., Hunt, L. P., Heath, P. T., & Finn, A. H. R. (2012) · Archives of Disease in Childhood · doi:10.1136/archdischild-2011-301163 · Cited by 45
Cost-effectiveness of adult pertussis vaccination in Germany
Lee, G. M., Riffelmann, M., & von König, C. H. W. (2008) · Vaccine · doi:10.1016/j.vaccine.2008.04.068 · Cited by 43
Allergic reactions to vaccines
Wood, R. A. (2013) · Pediatric Allergy and Immunology · doi:10.1111/pai.12102 · Cited by 42
Increased risk of anaphylaxis following administration of 2009 AS03-adjuvanted monovalent pandemic A/H1N1 (H1N1pdm09) vaccine
Rouleau, I., Serres, G. D., Drolet, J. P., Skowronski, D. M., Ouakki, M., Toth, E., Landry, M., Ménard, S., & Gagnon, R. (2013) · Vaccine · doi:10.1016/j.vaccine.2013.10.033 · Cited by 40
Safety of diphtheria, tetanus, acellular pertussis and inactivated poliovirus (DTaP–IPV) vaccine
Daley, M. F., Yih, W. K., Glanz, J. M., Hambidge, S. J., Narwaney, K. J., Yin, R., Li, L., Nelson, J. C., Nordin, J. D., Klein, N. P., et al. (2014) · Vaccine · doi:10.1016/j.vaccine.2014.03.063 · Cited by 39
Administering influenza vaccine to egg-allergic persons
Kelso, J. M. (2014) · Expert Review of Vaccines · doi:10.1586/14760584.2014.933079 · Cited by 39
Primary Prevention of HPV through Vaccination: Update on the Current Global Status
Brotherton, J. M. L., ZUBER, P. L. F., & Bloem, P. N. (2016) · Current Obstetrics and Gynecology Reports · doi:10.1007/s13669-016-0165-z · Cited by 41
Adverse events following immunization: perception and evidence
Bonhoeffer, J., & Heininger, U. (2007) · Current Opinion in Infectious Diseases · doi:10.1097/qco.0b013e32811ebfb0 · Cited by 39
Monovalent inactivated split-virion AS03-adjuvanted pandemic influenza A (H1N1) vaccine
Walker, W. T., & Faust, S. N. (2010) · Expert Review of Vaccines · doi:10.1586/erv.10.141 · Cited by 37
Fatal Anaphylaxis: Epidemiology and Risk Factors
Mikhail, I., Stukus, D., & Prince, B. (2021) · Current Allergy and Asthma Reports · doi:10.1007/s11882-021-01006-x · Cited by 25
Post-licensure surveillance of quadrivalent inactivated influenza (IIV4) vaccine in the United States, Vaccine Adverse Event Reporting System (VAERS), July 1, 2013−May 31, 2015
Haber, P., Moro, P. L., Lewis, P., Woo, E. J., Jankosky, C., & Cano, M. V. (2016) · Vaccine · doi:10.1016/j.vaccine.2016.03.048 · Cited by 37
Adverse events following immunization in patients with primary immunodeficiencies
Delgado, J. S., Villada, F., Orrego, J. C., Franco, J. L., & Trujillo-Vargas, C. M. (2016) · Vaccine · doi:10.1016/j.vaccine.2016.01.047 · Cited by 36
Promoting Vaccine Confidence
Smith, M. J. (2015) · Infectious Disease Clinics of North America · doi:10.1016/j.idc.2015.07.004 · Cited by 35
Managing a child with possible allergy to vaccine
Caubet, J., Rudzevičienė, O., Gomes, E. R., Terreehorst, I., Brockow, K., & Eigenmann, P. (2013) · Pediatric Allergy and Immunology · doi:10.1111/pai.12132 · Cited by 35
Post-marketing surveillance of immediate allergic reactions: polygeline-based versus polygeline-free pediatric TBE vaccine
Zent, O., & Hennig, R. (2004) · Vaccine · doi:10.1016/j.vaccine.2004.07.016 · Cited by 35
On-time Vaccine Receipt in the First Year Does Not Adversely Affect Neuropsychological Outcomes
Smith, M. J., & Woods, C. R. (2010) · Pediatrics · doi:10.1542/peds.2009-2489 · Cited by 34
Design of a robust infrastructure to monitor the safety of the pandemic A(H1N1) 2009 vaccination program in Taiwan
Huang, W., Chen, W., Yang, H.-W., Chen, W., Chao, Y.-N., Huang, Y.-W., Chuang, J.-H., & Kuo, H. (2010) · Vaccine · doi:10.1016/j.vaccine.2010.08.069 · Cited by 33
U.S. Postlicensure safety surveillance for adolescent and adult tetanus, diphtheria and acellular pertussis vaccines: 2005–2007
Chang, S., O’Connor, P. M., Slade, B. A., & Woo, E. J. (2012) · Vaccine · doi:10.1016/j.vaccine.2012.10.097 · Cited by 32
Pediatric anaphylactic adverse events following immunization in Victoria, Australia from 2007 to 2013
Cheng, D. R., Perrett, K. P., Choo, S., Danchin, M. H., Buttery, J. P., & Crawford, N. W. (2015) · Vaccine · doi:10.1016/j.vaccine.2015.02.008 · Cited by 32
Vaccination and allergy
Rottem, M., & Shoenfeld, Y. (2004) · Current Opinion in Otolaryngology & Head & Neck Surgery · doi:10.1097/01.moo.0000122312.13359.eb · Cited by 32
Measles vaccine
Strebel, P. M., Papania, M. J., Fiebelkorn, A. P., & Halsey, N. A. (2013) · Elsevier eBooks · doi:10.1016/b978-1-4557-0090-5.00028-8 · Cited by 31
Administration of influenza vaccines to patients with egg allergy
Kelso, J. M. (2010) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2010.02.013 · Cited by 31

Authors: Bohlke, K., Davis, R. L., Marcy, S. M., Braun, M. M., DeStefano, F., Black, S. B., Mullooly, J. P., Thompson, R. S., & for the Vaccine Safety Datalink Team
Affiliations: Group Health Cooperative (US)
Kaiser Foundation Hospital (US)
Center for Biologics Evaluation and Research (US)
Centers for Disease Control and Prevention (US)
Kaiser Permanente (US)
ORCID: Bohlke, Kari
Davis, Robert L.
Black, Steven B.
Thompson, Robert S.
Venue: PEDIATRICS
Publisher: American Academy of Pediatrics (AAP)
Published: 2003-10-01
Volume: 112
Issue: 4
Pages: 815-820
ISSN: 0031-4005 (ISSN-L)
1098-4275
DOI: 10.1542/peds.112.4.815
OpenAlex: W2111371073
Cited by: 320
References: 24
Citations by year: 2026: 2 · 2025: 7 · 2024: 9 · 2023: 8 · 2022: 11 · 2021: 14 · 2020: 5 · 2019: 14 · 2018: 16 · 2017: 11 · 2016: 16 · 2015: 17 · 2014: 16 · 2013: 14 · 2012: 25
FWCI: 6.71
Type: journal article
Language: en
Open access: closed
Locations: PEDIATRICS (publishedVersion)
PubMed (publishedVersion)
Funders: Kaiser Permanente
Centers for Disease Control and Prevention
Topics: Health Sciences › Medicine › Immunology and Allergy › Food Allergy and Anaphylaxis Research
Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Toxicology › Pharmacovigilance and Adverse Drug Reactions
Health Sciences › Medicine › Pharmacology (medical) › Drug-Induced Adverse Reactions
Keywords: vaccine anaphylaxis, vaccine safety, children and adolescents, MMR vaccine, hepatitis B vaccine, diphtheria-tetanus vaccine, Haemophilus influenzae type b vaccine, oral polio vaccine, vaccine adverse events, anaphylactic shock
MeSH terms: Adolescent, Anaphylaxis, California, Child, Child, Preschool, Female, Health Maintenance Organizations, Humans, Infant, Infant, Newborn, Male, Oregon, Risk, Vaccination, Vaccines, Washington, Cohort Studies, Adverse Drug Reaction Reporting Systems

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Risk of anaphylaxis after vaccination of children and adolescents.

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks